Lymphocyte predominant Hodgkin's disease: Pathology and clinical implication

Annals of Oncology

Volumn 9, Issue SUPPL. 5, 1998, Pages

  Franklin, J ^a   Tesch, H ^a   Hansmann, M L ^a   Diehl, V ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Histopathology; Hodgkin's disease; Lymphocyte predominance; Prognosis; Treatment strategy

Indexed keywords

CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONFERENCE PAPER; HODGKIN DISEASE; LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0032456810     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/9.suppl_5.S39     Document Type: Conference Paper

References (21)

1. Jackson H, Parker F. Hodgkin's discase II, pathology. N Engl J Med 1944; 231:35.
2. Lukes RJ, Buller JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res 1966; 26: 1063.
3. Lukes RJ, Butler JJ, Hicks EB. Natural history of Hodgkin's disease as related to its pathologic picture. Cancer 1966; 19: 317.
4. Poppema S. Lymphocyte-predominance Hodgkin's disease. Sem Diagn Pathol 1992; 9: 257.
5. Harris NL, Jaffe ES, Stein H, Banks PM et al. A Revised European-American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361.
6. Westling P. Studies of the prognosis in Hodgkin's disease. Acta Radiol 1965; 245 (Suppl): 5.
7. Rosenthal SR. Significance of tissue lymphocytes in the prognosis of lymphogranulomatosis. Arch Pathol 1936; 21: 628.
8. Jackson H, Parker F. Hodgkin's Disease and Allied Disorders. New York: Oxford University Press 1947.
9. Keller AR, Kaplan HS, Lukes RJ, Rappaport H. Correlation of histopathology with other prognostic indicators in Hodgkin's disease. Cancer 1968; 22: 487.
10. Gough J. Hodgkin's disease: A correlation of histopathology with survival. Int J Cancer 1970; 5: 273.
11. Peters MV. A study of survivals in Hodgkin's disease treated radiologically. Am J Roentgenol 1950; 63: 299.
12. Culine S, Henry-Amar M, Diebold J et al. Relationship of histological subtypes to prognosis in early stage Hodgkin's disease: A review of 312 cases in a controlled clinical trial. Eur J Cancer Clin Oncol 1989; 25: 551.
13. Bennett MH, MacLennan KA, Vaughan Hudson B, Vaughan Hudson G. The clinical and prognostic relevance of histopathologic classification in Hodgkin's disease. Progr Surg Pathol 1990; 10: 127.
14. Shankar AG, Ashlcy S, Radford M et al. Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group. J Clin Oncol 1997; 15: 2262.
15. Sextro M, Diehl V, Franklin J et al. for the European Task Force on Lymphoma. Lymphocyte predominance Hodgkin's disease a workshop report. Ann Oncol 1996; 7: 61.
16. Hansmann M-L, Zwingers T, Boeske A et al. Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular). J Cancer Res Clin Oncol 1984; 108: 321.
17. Borg-Grech A, Radford JA, Crowther D et al. A comparative study of the nodular and diffuse variants oflymphocyte-predominant Hodgkin's disease. J Clin Oncol 1989; 7: 1303.
18. von Wasielewski R, Werner M, Fischer R et al. Lymphocyte predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group. Am J Pathol 1997; 150: 793.
19. Bodis S, Kraus MD, Pinkus G et al. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease. J Clin Oncol 1997; 15: 3060.
20. Regula DP, Hoppe RT, Wciss LM. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. N Engl J Med 1988; 318: 214.
21. Orlandi E, Lazzarino M, Brusamolino E et al. Nodular lymphocyte predominance Hodgkin's disease: Long-term observation reveals a continuous pattern of recurrence. Leuk Lymph 1997; 26: 359.